Lilly expands pain pipeline via US$ 1 bn SiteOne buyout; US cancels funding for Moderna’s bird flu vaccine
In news this week, Eli Lilly has placed a billion-dollar bet on non-opioid pain management by acquiring SiteOne Therapeutics fo...
Impressions : 801
Sanofi to sell 50% stake in Opella to CD&R, to retain French workforce; AbbVie bags FDA nod for Parkinson’s therapy Vyalev
In this week’s Phispers, Sanofi has entered into exclusive talks with US private equity firm CD&R to sell a controlling 5...
Impressions : 1179
Three-shot course of Pfizer jab neutralizes Omicron; AbbVie, Pfizer, Lilly drugs hit by FDA’s strict safety warnings
In
this week's
Phispers, we bring you more news on Covid vaccines, mergers and acquisitions,
regulatory updates, and account...
Impressions : 2307
Gilead acquires Immunomedics for US$ 21 billion; FDA issues guidance on resuming normal manufacturing
This week, Phispers brings you news of two deals in the antibody drug conjugates (ADCs) space.
While Gilead bought cancer dru...
Impressions : 53588
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.